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Administration of probiotics to premature newborns has
been shown to prevent necrotizing enterocolitis and reduce
all-cause mortality. In our hospital, we documented 2 cases
of Biﬁdobacterium longum subspecies infantis bacteremia
in newborns receiving probiotics. By comparative genomics,
we conﬁrmed that the strains isolated from each patient orig-
inated from the probiotics.
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Enteral supplementation of premature newborns with probiot-
ics has been associated with a signiﬁcant reduction of necrotiz-
ing enterocolitis (NEC) and all-cause mortality [1]. Therefore,
probiotic products containing bacteria such as Biﬁdobacterium
longum subspecies infantis (hereafter called Biﬁdobacterium in-
fantis) are increasingly used in clinical practice. Yet, the possi-
bility of probiotics-associated sepsis remains a concern [2].
Indeed, other Biﬁdobacterium species have been documented
as agents of bacteremia [3], although generally among patients
with signiﬁcant underlying disease, such as neutropenia. We re-
port 2 cases of B. infantis bacteremia in very preterm infants re-
ceiving probiotics and compare the genome of both strains
recovered from blood cultures with strains recovered from com-
mercial preparations of the probiotics.
CASE REPORTS
Case 1
A female infant was born at 26 2/7 weeks of gestation by spon-
taneous vaginal delivery following premature rupture of mem-
branes. Birthweight was 867 g. She required nasal continuous
positive airway pressure with a maximum of 28% of oxygen.
A patent ductus arteriosus was closed using indomethacin treat-
ment. Enteral feeding was initiated on the ﬁrst day of life (DOL)
with her mother’s own milk. Amoxicillin and gentamicin were
started at birth and discontinued on DOL 3 due to a negative
blood culture. Inﬂoran (Lactobacillus acidophilus 5 × 108 colony-
forming units [CFU] and B. infantis 5 × 108 CFU twice daily)
was administered enterally from DOL 5 to DOL 14. On DOL
14, she developed symptoms suggestive of sepsis with tachycar-
dia, desaturation, and ileus. A complete blood count revealed
leukocytosis (28.5 × 109/L) with a left shift. Abdominal radio-
graphs were nonspeciﬁc with moderately dilated bowel loops.
The patient was treated with ceftazidime and vancomycin for
7 days for suspected central venous line–related sepsis. Due to
a second episode of feeding intolerance and intestinal disten-
sion, she received a 7-day course of imipenem, starting from
DOL 21. The anaerobic blood culture taken on DOL14 came
back positive for B. infantis. Clinical status improved for 2
weeks before a third episode of ileus. A contrast enema was con-
sistent with small bowel obstruction. A laparotomy performed
on DOL 40 revealed ileoileal intussusception requiring resection
of 15 cm of ileum and primary anastomosis. Histopathology
conﬁrmed the diagnosis of intussusception with intestinal ne-
crosis. The patient recovered postoperatively and was dis-
charged home at a postmenstrual age of 40 4/7 weeks.
Case 2
A female infant was born at 28 6/7 weeks of gestation by cesarian
section for spontaneous labor following a dizygotic twin pregnan-
cy. Birthweight was 1090 g. She required nasal continuous positive
airway pressure with 21% oxygen. Enteral feeding was initiated on
DOL 2 with her mother’s own milk. Amoxicillin and gentamicin
were started at birth and discontinued on DOL 3 due to a negative
blood culture. Inﬂoran was administered enterally from DOL 5 to
DOL 9. She presented on DOL 10 with abdominal distention, ten-
derness, ileus, and rapid clinical deterioration with hypotension,
lactic acidosis, thrombocytopenia, and coagulopathy requiring in-
tubation and multiple transfusions with fresh frozen plasma,
platelets, and blood. A complete blood count revealed leukopenia
(2.0 × 109/L) with a left shift, and C-reactive protein increased to
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240 mg/L. The clinical presentation together with radiologic evi-
dence of pneumatosis intestinalis and portal venous gas was con-
sistent with NEC stage III according to Bell’s criteria. The patient
was treated with ceftazidime, amikacin, and metronidazole. Blood
cultures taken on DOL 10 were positive for B. infantis. Enteral
feeding was reintroduced on DOL 22. Due to persistent feeding
intolerance, a laparotomy was performed on DOL 42, which re-
vealed intestinal necrosis and jejunal perforation requiring resec-
tion of 25 cm of small intestine and a primary anastomosis. The
patient recovered from surgery and was discharged home at a
postmenstrual age of 40 4/7 weeks.
BACTERIAL GENOMICS
Eight bacterial strains were sequenced (Supplementary Data) to
ascertain that the 2 B. infantis strains causing bacteremia in
these neonates originated from the Inﬂoran capsules, and to in-
vestigate the occurrence of mutations that could have triggered
an increased virulence. Two B. infantis strains were isolated
from blood cultures, and 6 strains were retrieved directly from
capsules of Inﬂoran (Figure 1A).
Average nucleotide identity conﬁrmed that all strains be-
longed to the species B. longum subspecies infantis (Supple-
mentary Table 1). All strains were highly similar and no
region was uniquely found in the strains that caused bacteremia
(BIC1206122787 and BIC1401111250) compared with strains
retrieved from Inﬂoran capsules. Most of the differences
observed between genomic sequences were apparently due to
the assembly software that stops elongating contigs at slightly
different positions.
To conﬁrm the clonality of patient strains and probiotics strains,
an analysis of single-nucleotide polymorphisms (SNPs) was car-
ried out using kSNP V2.1.2 software on all complete genomes
of B. longum available in public databases as well as on the draft
genomes of all strains sequenced in the present study (Figure 1B).
SNP calling by mapping reads of each strain against strain
BIC1307292462 identiﬁed between 4 and 8 SNPs (Figure 1A and
Supplementary Table 2). Although one could have expected that
strains recovered from the same capsule (BIC1401212621a and
BIC1401212621b, BIB1401272845a and BIB1401272845b) would
be more similar, no common SNP was found between these pairs
of genomes. In addition, in 2 cases, common SNPs were found
between a capsule strain and a patient strain (Supplementary
Table 2). The strains BIC1206122787 from case 1 and BIC140
1111250 from case 2 presented 2 and 3 unique SNPs, respectively,
but did not have any SNP in common (Supplementary Table 2).
DISCUSSION
Among the >5000 premature newborns who have been included
in trials of probiotics prophylaxis, no cases of probiotics-
associated sepsis have been reported [1]. A recent review of
the literature [4] identiﬁed 2 cases of bacteremia associated
with probiotics in premature newborns [5, 6]. Therefore, probi-
otic-associated sepsis is likely to be a rare event in premature
newborns. However, the true incidence could be underestimat-
ed, as anaerobic blood cultures are not always obtained in new-
borns with suspected infection. Moreover, as underlined by
Tena et al, when identiﬁed from other sources, Biﬁdobacterium
may be overlooked, since they are generally considered as non-
pathogenic bacteria [7]. Indeed, these anaerobic gram-positive
nonsporulating rods are part of the physiological oral, vaginal,
and intestinal ﬂora [8].
In our ﬁrst patient, intussusception was diagnosed 3 weeks
after the episode of Biﬁdobacterium sepsis. Because intussus-
ception is extremely rare in premature newborns and presents
with unspeciﬁc symptoms that often lead to a delayed diag-
nosis [9], we cannot conﬁrm or refute a causal relationship be-
tween Biﬁdobacterium sepsis and intussusception. The second
patient was affected by advanced NEC, which could not be
prevented by administration of probiotics. We speculate that
the presence of Biﬁdobacterium in blood cultures is likely to
be the consequence of intestinal necrosis rather than the
cause of NEC. However, Biﬁdobacterium translocation could
have an impact on intestinal necrosis and systemic inﬂamma-
tion in premature newborns who develop NEC despite probi-
otic therapy.
The small number of SNPs identiﬁed between both strains
isolated from blood culture and all strains recovered from pro-
biotics suggests that the strains involved in bacteremia were
originating from probiotics. Moreover, the pattern of SNPs ob-
served indicates that the probiotic capsules contain mixed but
stable populations of B. longum strains all belonging to the in-
fantis subspecies, but exhibiting few mutations in their ge-
nomes. Bacterial culture was minimized to a single passage
for clone picking followed by a second culture to obtain sufﬁ-
cient DNA for subsequent analysis. The occurrence of mutation
during culture at the bacteriology diagnostic laboratory should
thus be insigniﬁcant and the variant should not have reached
ﬁxation in the bacterial population. The 2 strains that caused
bacteremia do not share a particular SNP, but each strain pre-
sents some unique SNPs. Although to our knowledge these mu-
tations arose in various proteins that were not previously linked
to increased virulence, mutations observed in the type IV secre-
tory pathway virB4 component, in a transcriptional regulator,
or in a hypothetical protein might have provided an increased
virulence to the bacterium.
CONCLUSIONS
We identiﬁed 2 cases of bacteremia in very preterm infants that
likely resulted from the administration of probiotics. Thus, the
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safety of routine clinical use of probiotics is questioned in this
population. Future clinical trials should include surveillance of
blood cultures aimed at detecting anaerobic bacteria and long-
term follow-up of infants with probiotic-associated bacteremia.
This work also underlines the usefulness of rapid bacterial ge-
nome sequencing to explore the relatedness of different strains,
Figure 1. Timeline of events and phylogeny. A, Timeline of events for clinical cases and strain retrieval. Clinical information is shown in black. Strains
retrieved from blood culture are shown in purple. Strain BIC1206122787 was retrieved from blood culture of case 1 in 2012. Strain BIC1401111250 was
retrieved from blood culture of case 2 in 2014. Strains retrieved from Inﬂoran capsules of the University Hospital of Lausanne are shown in green. Strain
BIC1307292462 was isolated by culture of an Inﬂoran capsule in 2013 and is unrelated to any of the previously mentioned cases. Strains BIC1401212621a
and BIC1401212621b were grown from 2 colonies isolated from a single Inﬂoran capsule recovered at our institution in 2014, at the time of case 2 bacter-
emia. The capsule likely belongs to the same lot as the Inﬂoran capsules administered to case 2, even though the lot number of the capsule administered to
patient 2 was not recorded. Strains cultured from Inﬂoran capsules obtained from the neonatal intensive care unit of the Charité University Hospital Berlin
(Germany) are shown in brown (BIB1401242951, BIB1401272845a, and BIB1401272845b). The Charité University Hospital Berlin claims no case of bacter-
emia due to B. infantis. BIB1401272845a and BIB1401272845b are 2 colonies grown from the same capsule of Inﬂoran. B, Phylogenetic relatedness of
Biﬁdobacterium longum strains. This ﬁgure represents the phylogenetic tree of all B. longum strains available as full genome sequences in public databases
as well as the 8 strains investigated in this study. The tree was inferred using maximum likelihood as part of the software kSNP. Similar to (A), strains
retrieved from blood culture are shown in purple, and strains retrieved from Inﬂoran capsules are shown in green. Capsules from the Charité University
Hospital Berlin are displayed in brown. The support is shown next to each node.
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in such settings, with a much better resolution than multilocus
sequence typing or pulsed-ﬁeld gel electrophoresis.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online
(http://cid.oxfordjournals.org). Supplementary materials consist of data
provided by the author that are published to beneﬁt the reader. The posted
materials are not copyedited. The contents of all supplementary data are the
sole responsibility of the authors. Questions or messages regarding errors
should be addressed to the author.
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